AVANIR PHARMACEUTICALS (AVNR)

[Prudent Capitalist]

Let's hope Kramer takes note too. Piper Jaffray is a recognized and respected firm with a great reputation. To have a firm of its stature on Wall Street putting this $13 price target out is huge.

But, let's also remember that AVNR has a history of being manipulated, and we can expect some funny business out of the MM's as they will likely try to take the PPS down to allow more shorts to cover.